Successfully launching an orphan drug on a tight budget

Client Challenge

Small biotech with skeleton staff commercializing their first orphan drug launch in-house.

The client had limited resources and know-how.

P4A Solution

P4A analyzed current situation into a short / medium term needs assessment.

The launch activities were planned by clearly defined priorities essential to success:
  • Engaging key stakeholders
  • Closing essential economic data gaps
  • Country launch sequencing

The Successful Outcome

  • 142% reduction in launch plan expenditure
  • Significant increase in share price
  • Replaced need for phase IV study
I am so pleased that we chose P4A to support us with this work, they have gone above and beyond to ensure we’ve got what we need to make our launch a success.
Global Commercial Lead